The AMA's willing entry into active myth-busting and evidence-based debunking is a long-overdue and vital institutional ...
The FDA is requiring manufacturers of all GLP-1 drugs to update their prescribing information to include a warning about the ...
ML-007C-MA, an investigational muscarinic M1/M4 receptor agonist that combines betovumeline and fesoterodine fumarate, ...
Starting valbenazine (Ingrezza) to treat tardive dyskinesia might reduce antipsychotic discontinuation in patients newly ...
The FBI is aiding in an investigation over the death of Heather Kovich, MD, a prominent family medicine physician in New ...
About one in four adults endorsed vaccines or prenatal acetaminophen (Tylenol) as autism risks in a large U.S. survey. About ...
ORLANDO -- Interim results from a prospective trial designed to evaluate safety of avacopan (Tavneos), the embattled drug for ...
Left bundle branch pacing (LBBP) drastically reduced clinical events among patients with atrioventricular (AV) block, with ...
In patients with chronic hepatitis delta (CHD) with cirrhosis, treatment with bulevirtide (Hepcludex) was associated with ...
ORLANDO -- Patients with systemic lupus erythematosus (SLE) that is uncontrolled despite standard therapy did well with a ...
Smartwatch detection of LVSD has appeal for making it easier and more accessible to detect LVSD in people with heart failure ...
The blowup began when Calley Means, a former top advisor to Health Secretary Robert F. Kennedy Jr. and a chief advocate for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results